tiprankstipranks

Noah Goodman Insider Profile

4 Followers
Noah Goodman, CBO at Kymera Therapeutics, holds 50.20K shares in Kymera Therapeutics (Ticker: KYMR).
tipranks
Noah Goodman

Noah Goodman
Kymera Therapeutics (KYMR)
CBO

Not Ranked
Noah Goodman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Noah Goodman's holdings

Insider Roles

Kymera Therapeutics
(KYMR)
CBO
Roles that Noah Goodman holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Noah Goodman

Noah Goodman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kymera Therapeutics
Apr 16, 2026
CBO
Uninformative Sell
121.23K
$4.05M
Noah Goodman has not reported any informative transactions for KYMR, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Apr 09, 2025
Uninformative Buy
$0.00
50,000
$0.00
Mar 04, 2026
Uninformative Buy
$0.00
9,225
$0.00
Apr 10, 2026
Uninformative Sell
$283.45K
3,264
$86.84
Apr 10, 2026
Uninformative Sell
$397.20K
4,500
$88.26
Apr 16, 2026
Uninformative Sell
$121.23K
1,347
$90.00
List of latest transactions for each holding click on a transaction to see Noah Goodman's performance on stock

Noah Goodman insider profile FAQ

What is the percentage of profitable transactions made by Noah Goodman?
The percentage of profitable transactions made by Noah Goodman is ―.
    What is the average return per transaction made by Noah Goodman?
    The average return per transaction made by Noah Goodman is ―.
      What stocks does Noah Goodman hold?
      Noah Goodman holds: KYMR stocks.
        What was Noah Goodman’s latest transaction?
        Noah Goodman latest transaction was an Uninformative Sell of $121.23K.
          What was Noah Goodman's most profitable transaction?
          Noah Goodman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Noah Goodman's role in Kymera Therapeutics?
            Noah Goodman's role in Kymera Therapeutics is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.